Skip to main content
. 2019 Dec 26;21:150. doi: 10.1186/s13058-019-1227-8

Fig. 5.

Fig. 5

ERX-11+palbociclib treatment alters ER interactions with coregulators. ad MCF-7 cells were treated with E2 (10−8 M) in the presence or absence of ERX-11 (10 μM), palbociclib (0.25 μM), or ERX-11+palbociclib for 2 h. Cell lysates from treated cells were subjected to immunoprecipitation with ERα antibody. The immunoprecipitates were analyzed by mass spectrometry